Safety and Tolerability of the First IV Dosing of SLV338 in Healthy Volunteers

NCT00885989 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: SLV338
DRUG: Placebo

Sponsor

Solvay Pharmaceuticals